Un-audited (Consolidated and Standalone) financial results for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Agribio Spirits Limited posted standalone revenue from operations of ₹736.31 lakhs in Q1FY26 versus just ₹56.19 lakhs in Q1FY25, a massive jump driven mainly by the pending merger with Agribiotech Industries Limited (approved Dec 31, 2024, still awaiting approvals). Standalone PAT rose to ₹41.46 lakhs (₹0.38 EPS) from ₹8.37 lakhs (₹0.11 EPS). Consolidated PAT (including share of associate profit of ₹56.77 lakhs) was ₹98.23 lakhs versus ₹63.07 lakhs, with consolidated EPS at ₹0.90 vs ₹0.82. Cost of materials consumed stood at ₹728.33 lakhs, eating up roughly 99% of revenue, indicating very thin standalone margins. Auditor RP Khandelwal & Associates issued an unmodified limited review report.
The headline revenue and PAT growth look stellar but are largely distorted by the pending Agribiotech merger and inclusion of associate profits; standalone operating margins have compressed sharply, so shareholders should treat the YoY jump with caution until the merger is fully effective and like-to-like comparisons are possible. The board changes and re-designation of Mr. Kamal Kishor Sharma as Chairman are routine governance matters.